The post above is notable for several reasons.
The peroration being the Syngenta applause it attracts which may just be Syngenta congratulating their Chemart buddies ...but Eden's alignment with a company with strong Sumitomo and Syngenta relationships does add fuel to the speculation about the dual role of our recently appointed Syngenta Linkman. |
Chemark Zrt.
We are proud to announce that Chemark has successfully passed a CAAE audit. The audit reviewed the manufacturing process of CEDROZ PRO, an Eden Research product certified by CAAE for Eastman. The evaluation confirmed compliance with Regulation (EU) 2018/848 and the Input Standard UNE 315500. This certification validates the product's suitability for use in organic farming. |
Oh give it up you f’ing baffoon. You really are a lunatic. |
 CDPR Releases New Schedule for Pesticide Reevaluations Across California
The California Department of Pesticide Regulation (CDPR) has released its updated schedule for reevaluating certain pesticides registered in the state. Under state law, CDPR must continuously review pesticides to determine if they pose significant adverse impacts or if further restrictions are needed. This process involves scientific assessments, public workshops, and, if required, regulatory actions such as label changes or cancellations.
The new schedule includes several pesticides currently under reevaluation. For chloropicrin, manufacturers must complete multiple studies by 2025. CDPR plans to finish reviewing these studies by 2027 and, if additional rules or actions are warranted, finalize any changes by 2029. Cyfluthrin is also under review, with a human health risk assessment scheduled for completion by late 2026. Any further action would be wrapped up by the end of 2028.
com/cdpr-releases-new-schedule-pesticide-reevaluations-across-california/?_fl_id=f7b7c6c2-c272-45d6-8530-4c503a933cbf&em=cGFtbWFycm9uZUBzYmNnbG9iYWwubmV0&utm_campaign=AgNet+West+This+Week+1-10-2025 |
How Did Biological Companies Perform in 2024?
Frederic Beudot, Vice President, Biologicals, Corteva Agriscience:
More and more farmers adopt Biologicals as another critical tool to use as part of their integrated pest management and soil health systems. As a result, we saw interest in our Biologicals offering continue to increase throughout 2024 and are expecting double-digit EBITDA growth for the year. Biologicals can extend the efficacy of synthetic chemicals when used in rotations, improve soil health, enhance resistance management, and enable plants to better utilize all the resources around them, all things that make the plant stronger and more resilient. We’re excited by the future of this technology and what it can mean for growers. |
£10K accumulator Alyx.. happy with delays... buys more today? |
ravenna23, no need to keep our chat off-board.
How many more dilutions do you think the C's-in-Charge think they can get away with? With "investors" this naive as Timbo_Slice aka Northwick aka (ad nauseam), I can see how they are tempted to run this forever instead of cutting and running one step ahead of the .... |
That would be a very good way of raising some funds. |
Re Insecticide.
Might we see the lead distributor ..perhaps Syngenta or Corteva buy in to Eden as part of this deal?..
Why is it taking so long to finalise? |
How long before we see Eden tech in something like this via Bluesun ? |
Disappointed with the increase in losses and the cash in bank figure. If Eden doesn’t raise cash by end of the year I’ll be amazed. On the positive side, I think that’ll be the last time. |
Investing I am a bit grumpy with a full on cold. Apologies. Yes the buses when they turn up will make a huge difference . I'm at a request stop have been for quite a while . |
Yes I get that |
Alchemy
Read the RNS. 16% is WITHOUT the BIG buses. |
So we add Spain and Mexico and we grow but 16% And that's with the buses or no? That's another whole year of no profits and tidgy growth . We need the buses to be double-deckers. |
Register for real-time alerts, custom portfolio, and market movers
Hot Features
Premium
